PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Processa Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.73+0.04 (+2.37%)
Close on Oct 19, 2026
- Market cap
- $4.76M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Processa Pharmaceuticals has not reported a dividend
No dividend per share appears in Processa Pharmaceuticals's annual filings since fiscal 2011.